STRATA Skin Sciences, Inc.
strataskinsciences.comWhat Do They Do?
Supplies XTRAC lasers for dermatologists treating skin disorders, plus VTRAC lamps and TheraClear acne-treatment systems for dermatologists and dermatology clinics.
10-K for FY2025, filed Mar 26, 2026We are a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of…View ↗
The XTRAC excimer laser technology emits highly concentrated UV light targeted primarily towards autoimmune dermatological skin disorders…View ↗
In January 2022, we acquired the TheraClear assets from Theravant Corporation. The TheraClear Acne Therapy System delivers a two-part…View ↗
CustomersView ↗
How Do They Make Money?
Dermatologists pay fees for set numbers of XTRAC treatment sessions or a specified period, with extra fees for treatments beyond the agreed amount; customers and distributors also buy laser and lamp equipment.
10-K for FY2025, filed Mar 26, 2026Revenues from the Company’s dermatology recurring procedures customers are earned by providing physicians with its laser products and…View ↗
Revenues from the Company’s dermatology procedures equipment are recognized when control of the promised goods or services is transferred…View ↗
The Company has organized its business into two operating segments to better align its organization based upon the Company’s management…View ↗
-
10-K for FY2025, filed Mar 26, 2026
FY2025 revenue by reportable segment ↗
$30.7M
-
10-K for FY2025, filed Mar 26, 2026
$30.7M ↗
| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Dermatology Recurring Procedures
|
70%
FY2022: 64%
|
Dermatology Recurring Procedures, FY2025
$21.5M Sources
|
|
|
Dermatology Procedures Equipment
Sold outright
10-K for FY2025, filed Mar 26, 2026 |
30%
FY2022: 36%
|
Dermatology Procedures Equipment, FY2025
$9.2M Sources
|
Sold outright |
Who Are Their Customers?
U.S. customers are dermatologists and dermatology group clinics that partner for XTRAC procedures. International sales use country-specific distribution agreements for equipment and recurring revenue.
10-K for FY2025, filed Mar 26, 2026CustomersView ↗
Domestically, our XTRAC customers consist of dermatologists and dermatological group clinics who partner with us primarily in our…View ↗
Since 2019, we have transitioned our international dermatology procedures equipment sales through our master distributor to a direct…View ↗
Our non-U.S. business focuses on a direct distribution model for equipment sales and recurring revenue, and we have distribution agreements…View ↗
10-K for FY2025, filed Mar 26, 2026
The Company had one customer, an international distributor, from which it primarily earns dermatology procedures equipment revenues, that…View ↗
Do Revenues Turn Into Profits?
No. It lost $6.3M in FY2025.
How Are They Changing?
Flat. Revenue was $30.7M in FY2025, about the same as the $30M of FY2021.
Pharos product line
The older report listed Pharos excimer lasers; the latest says the Pharos device is no longer available and notes its line was discontinued.
10-K for FY2022, filed Mar 31, 2023 10-K for FY2025, filed Mar 26, 2026We are a medical technology company in dermatology dedicated to developing, commercializing and marketing innovative products for the…View ↗
Who Do They Compete With?
Competes with The Daavlin and National Biologic
10-K for FY2025, filed Mar 26, 2026Our XTRAC product line competes with pharmaceutical compounds and methodologies used to treat an array of skin conditions. Such alternative…View ↗
Loading...
